A Study of CS1001 in Subjects With Gastric Adenocarcinoma or Gastro-Esophageal Junction Adenocarcinoma

Clinical trial NCT03802591 · COMPLETED

Trial details

NCT number: NCT03802591
Sponsor: CStone Pharmaceuticals
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Gastric Adenocarcinoma Gastroesophageal Junction Adenocarcinoma

Start date: 2019-03-28
Primary completion: 2023-07-09
Enrollment: 479

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.